Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation

• Published in: Biochemistry (Moscow) Vol. 88; no. 8; pp. 1061 - 1069
• Main Authors: Mazin, Mark E., Perevalova, Alina M., Yarushkin, Andrei A., Pustylnyak, Yuliya A., Rogachev, Artem D., Prokopyeva, Elena A., Gulyaeva, Lyudmila F., Pustylnyak, Vladimir O.
• Format: Journal Article
• Language: English
• Published: Moscow Pleiades Publishing 01.08.2023; Springer; Springer Nature B.V
• Subjects: Agonists; Agonists (Biochemistry); Amino acids; Animal tissues; Benzene; Biochemistry; Biomedical and Life Sciences; Biomedicine; Biomolecules; Bioorganic Chemistry; Cell proliferation; Chemical compounds; Energy metabolism; Energy resources; Hepatocytes; Hyperplasia; In vivo methods and tests; Life Sciences; Liquid chromatography; Liver; Liver cells; Mass spectrometry; Mass spectroscopy; Metabolism; Metabolites; Microbiology; Nucleotides; Physiological aspects; Physiological research; Receptors; Statistical analysis; Substrates; Xenobiotics; Russia; TCPOBOP; hepatocyte; constitutive androstane receptor; liver; metabolomics
• ISSN: 0006-2979; 1608-3040
• DOI: 10.1134/S0006297923080023

Activation of the constitutive androstane receptor (CAR, NR1I3) by chemical compounds induces liver hyperplasia in rodents. 1,4-Bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP), a mouse CAR agonist, is most often used to study chemically induced liver hyperplasia and hepatocyte proliferation in vivo . TCPOBOP is a potent murine liver chemical mitogen, which induces rapid liver hyperplasia in mice independently of liver injury. In recent years, great amount of data has been accumulated on the transcription program that characterizes the TCPOBOP-induced hepatocyte proliferation. However, there are only few data about the metabolic requirements of hepatocytes that divide upon exposure to xenobiotics. In the present study, we have employed liquid chromatography – mass spectrometry technology combined with statistical analysis to investigate metabolite profile of small biomolecules, in order to identify key metabolic changes in the male mouse liver tissue after TCPOBOP administration. Analysis of biochemical pathways of the differentially affected metabolites in the mouse liver demonstrated significant TCPOBOP-mediated enrichment of several processes including those associated with nucleotide metabolism, amino acid metabolism, and energy substrate metabolism. Our findings provide evidence to support the conclusion that the CAR agonist, TCPOBOP, initiates an intracellular program that promotes global coordinated metabolic activities required for hepatocyte proliferation. Our metabolic data might provide novel insight into the biological mechanisms that occur during the TCPOBOP-induced hepatocyte proliferation in mice.